Press Releases about Tcr2 Therapeutics Inc
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://mms.businesswire.com/media/20230426005880/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://mms.businesswire.com/media/20230308005893/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://spotlightgrowth.com/wp-content/uploads/2023/03/TCR2-Therapeutics-NASDAQ-TCRR-Adaptimmune-NASDAQ-ADAP-Merger-Spotlight-Growth.jpg)
Via Spotlight Growth
![](https://mms.businesswire.com/media/20230306005534/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
TCR² Therapeutics Announces Pipeline Priorities for 2023
January 05, 2023
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference
November 23, 2022
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.